Yahoo Web Search

Search results

1. finance.yahoo.com › news › attention-deficitAttention Deficit Hyperactivity Disorder ... - Yahoo Finance

   finance.yahoo.com › news › attention-deficit

   • Cached

   Dec 10, 2023 · The global increase in mental health awareness is creating a positive outlook for the ADHD therapeutics market.Rockville , Dec. 10, 2023 (GLOBE NEWSWIRE) -- Expanding at 6.2% CAGR from 2024 to ...

   • Adults with ADHD are at a higher risk for developing dementia ...

     Adults with ADHD are nearly three times more likely to...

   • Alcobra Ltd. - Ordinary Shares (ADHD) - Yahoo Finance

     Top Mutual Funds. Find the latest Alcobra Ltd. - Ordinary...

2. finance.yahoo.com › news › adhd-startups-explodingADHD startups are exploding, and now there's even a dedicated ...

   finance.yahoo.com › news › adhd-startups-exploding

   • Cached

   Mar 7, 2023 · Ukrainian-originated startup Numo is an app for adults with ADHD that gamifies daily tasks and get support. Healios raised a £7 million ($9.9 million) Series A round to expand its platform across ...

3. www.yahoo.com › news › study-shows-adhd-cases-riseNew study shows ADHD cases are on the rise—and now ... - Yahoo

   www.yahoo.com › news › study-shows-adhd-cases-rise

   • Cached

   May 24, 2024 · According to the CDC, one in nine kids in the U.S. have now been diagnosed with ADHD. The researchers behind the report found that in 2022, 7.1 million kids in that age range received a new ADHD ...

4. news.yahoo.com › news › alcobra-ltd-adhd-jumps-stockAlcobra Ltd. (ADHD) Jumps: Stock Rises 8.7% - Yahoo News

   news.yahoo.com › news › alcobra-ltd-adhd-jumps-stock

   • Cached

   Jun 12, 2014 · June 12, 2014. Alcobra Ltd. ( ADHD) was a big mover last session, as the company saw its shares rise by roughly 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now over 27% in the past one-month time frame.

5. www.yahoo.com › news › adhd-drug-shortage-showsADHD drug shortage shows signs of letting up, but ... - Yahoo

   www.yahoo.com › news › adhd-drug-shortage-shows

   • Cached

   May 21, 2024 · People with ADHD may have trouble paying attention, act impulsive or may seem restless. ADHD medications, such as Adderall, aim to improve concentration and focus, while reducing impulsive ...

6. People also ask

   Are ADHD medications back in stock?

   • A total of nine manufacturers now have ADHD medications back in stock, according to the FDA’s drug shortage database, up from six last September. Teva Pharmaceuticals, a major manufacturer of ADHD medications, has resolved all of its shortages after certain doses were unavailable for several months, according to the agency’s database.

   ADHD drug shortage shows signs of letting up, but some patients still st…

   www.yahoo.com/news/adhd-drug-shortage-shows-signs-120000784.html

   See all results for this question

   How much is the ADHD market worth in 2034?

   • The market is forecasted to reach a valuation of US$ 45.51 billion by 2034-end. Rapidly rising incidence of mental health disorders, growing awareness about ADHD symptoms, rising availability of attention deficit hyperactivity disorder treatments and therapies, and high investments in ADHD research are key market drivers.

   Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Siz…

   finance.yahoo.com/news/attention-deficit-hyperactivity-disorder-adhd-220000543.html

   See all results for this question

   What is the value of the ADHD therapeutics market in 2024?

   • The global ADHD therapeutics market is estimated at a value of US$ 25.05 billion in 2024. Revenue from ADHD therapeutics is predicted to rise at a CAGR of 6.2% from 2024 to 2034. The market is forecasted to reach a valuation of US$ 45.51 billion by 2034-end.

   Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Siz…

   finance.yahoo.com/news/attention-deficit-hyperactivity-disorder-adhd-220000543.html

   See all results for this question